Online Program Home
My Program

Legend:
CC = Vancouver Convention Centre   F = Fairmont Waterfront Vancouver
* = applied session       ! = JSM meeting theme

Activity Details

468 * ! Wed, 8/1/2018, 8:30 AM - 10:20 AM CC-West 120
Blinded Data Reviews Are Necessary in Today's Clinical Trials — Topic Contributed Papers
Biopharmaceutical Section
Organizer(s): Ibrahim Turkoz, Janssen Research and Development, LLC
Chair(s): Ibrahim Turkoz, Janssen Research and Development, LLC
8:35 AM Predicting the Timing of the Final Event by Fitting B Splines to Poisson Intensity Rates

Marcus Sobel, Temple Universisity; Ibrahim Turkoz, Janssen Research and Development, LLC
8:55 AM Estimating Event Rate Differences Using Data from Blinded Trials
A. Gould, Merck Research Laboratories; Bill Wang, Merck
9:15 AM Bayesian Blinded Sample Size Adjustment for Risk Differences

Andrew Hartley, PPD, Inc.
9:35 AM Blinded vs. Unblinded Sample Size Re-Estimation: When and What?
Yili Pritchett, MedImmune
9:55 AM Tools and Techniques for Blinded Data Reviews in Ongoing Clinical Trials
Suresh Ankolekar, Cytel Inc.; Hrishikesh Kulkarni, Cytel Inc.
10:15 AM Floor Discussion